Product Information

GABAPENTIN 100 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0209 per EA under NDC 69097081312. Its NADAC has been published 524 times since Aug 10, 2016.

FDA first approved this application on Dec 30, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 100 MG CAPSULE

GABAPENTIN
$0.0209per EA

Strength

100 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097081312

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA090705

FDA Approved

12/30/2009

TE Code

AB

On Market Since

6/29/2016

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 100 MG CAPSULE has been published 524 times since Aug 10, 2016, and over the history we have for it it has declined 28.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0209 per EA
All-time high$0.0374 (Nov 14, 2018)
All-time low$0.0186 (Nov 20, 2024)
52-week high$0.0221
52-week low$0.0208
Median price$0.0279
Average price$0.0278
Largest weekly change+24.9% (Jul 18, 2018)
Weeks tracked524
Tracking sinceAug 10, 2016

Price History

1W

+1.0%

1M

-0.1%

3M

-1.0%

6M

-1.4%

1Y

-5.1%

3Y

-16.8%

5Y

-32.1%

All

-28.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GABAPENTIN 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0209 per EA (NDC 69097081312), effective Aug 19, 2026.

How has the price of GABAPENTIN 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has declined 28.9%. It has been tracked across 524 weekly CMS publications since Aug 10, 2016.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?

Since Aug 10, 2016, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0186 (Nov 20, 2024) to a high of $0.0374 (Nov 14, 2018), with a median of $0.0279 per EA.

Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 100 MG CAPSULE?

GABAPENTIN 100 MG CAPSULE (NDC 69097081312) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.